LIAISON - Borrelia IgM Quant

The LIAISON^® Borrelia IgM II assay uses chemiluminescence immunoassay (CLIA) technology for the quantitative determination of specific IgM antibodies to Borrelia burgdorferi sensu lato in human serum, plasma or cerebrospinal fluid (CSF) samples. The test has to be performed on the LIAISON^® analyzer family.